Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Wheat Ridge CO, Lee's Summit MO, Las Vegas NV,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Englewood CO, Sandy City UT, Salt Lake City UT,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Denver CO, Albuquerque NM, Overland Park KS,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07304089
Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Aurora CO, Santa Fe NM, Omaha NE, Phoenix AZ, Dallas TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Aurora CO, Lone Tree CO, Colorado Springs CO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
for
HIV Infection
Location: Aurora CO, Los Angeles CA, Memphis TN, Houston TX,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0
Code: NCT02140255
Phase1, Phase2, Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Aurora CO, Saint Joseph MO, Gilbert AZ, Springfield MO,